Delivery Order V797D70102-36C25218F2769
Award Date 3/6/18
Potential Completion Date 6/30/18
Potential Value $27K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,095.54 to AmerisourceBergen Drug Corp for Ramelteon 8 mg tablets (30-count supply) on August 22, 2025, with completion targeted for August 25, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Ramelteon is a prescription sleep aid medication used in the treatment of insomnia, reflecting the Defense...
- This is a firm fixed-price delivery order issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company that specializes in developing and manufacturing medications to treat rare neurological diseases and sleep disorders. The award is for the supply of WAKIX (pitolisant) tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract has a ceiling value of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ramelteon 8 mg tablets in unit dose packaging (50 count) with a firm fixed price ceiling value of $2,669.48. This non-set-aside competitive award is scheduled for completion by August 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor...
- This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a pharmaceutical company, for the supply of WAKIX (pitolisant) 17.8 mg tablets. The contract has a ceiling value of $5,209.20 and a performance period ending on February 14, 2025. The order was placed against Harmony Biosciences' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). This indicates that Harmony Biosciences has a broader,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $89,490 to Amerisourcebergen Drug Corporation to supply 4561368131 Ramelteon 8 mg tablets. As the prime contractor, Amerisourcebergen will deliver 30 units of the specified pharmaceutical to a facility in Conshohocken, Pennsylvania, under a contract running from June 28 through June 29, 2023. The order is funded through the Defense Logistics Agency's pharmaceutical procurement programs and is not designated for...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RAMELTEON 8 MG TABLET UD 50S, a medication used for the treatment of insomnia. The contract has a ceiling value of $6,418.61 and a period of performance through February 24, 2025. This contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...
- This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company that specializes in developing and manufacturing medications to treat rare neurological diseases and sleep disorders. The contract, valued at $5,085.00, is for the supply of WAKIX (pitolisant) 17.8 mg tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients....
- This delivery order for eszopiclone 3 mg tablets was awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp on October 5, 2023. The order is for 30 tablets with a firm fixed price of one hundred twenty-seven dollars and is to be completed by October 6, 2023. The place of performance is Conshohocken, Pennsylvania. No set-aside designation was used for this order, which was issued against an existing prime vendor contract vehicle to supply pharmaceutical...
- The Defense Logistics Agency Troop Support Medical awarded a $31,400 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of 10mg Zaleplon. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from July 11, 2023 through July 12, 2023 to supply the insomnia medication to DLA Troop Support Medical. No major subcontractors or set aside designations were identified. The...
- The Defense Logistics Agency awarded a $13,528.93 delivery order to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets (30-count units) on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. SUNOSI (solriamfetol) is a wakefulness-promoting agent used in the treatment of excessive...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- V797D70102Federal Supply Schedule
- V797D70102-36C25218F2769Delivery Order
TASIMELTEON
Posted 3/6/18
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Vanda Pharmaceuticals 03-01-2017-02-28-2017 | 651B | Department of Veterans Affairs National Acquisition Center | Award Notice 1/1 | 3/2/17, 8:56 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.2k | 3/6/18 |